Home » Conferences & Events » Health Care » Reimbursement and Health Policy

Reimbursement and Health Policy

The 340B Drug Discount Program
February 12, 2013

Congress created the 340B program in 1992 to help uninsured indigent patients gain better...

The Reimbursement Landscape for Novel Diagnostics: Current Limitations.
January 6, 2011

Personalized medicine has the potential to revolutionize patient care. The fundamental goal in...

BioBytes: The Biotech Drug Delivery Timeline
June 23, 2010

Biotech research holds a great deal of promise for future innovation in the treatment of...

Healing, Fueling, Feeding: How Biotechnology Is Enriching Your Life.
May 1, 2010

Biotechnology is all around us and is already a big part of our lives, providing breakthrough...

More Articles →

Letters, Testimony & Comments

BIO’s comments on the Centers for Medicare and Medicaid Services’ (CMS) draft 2014 Call Letter
March 1 2013
Medicaid, Children’s Health Insurance Programs, and Exchanges
February 21 2013
The Biotechnology Industry Organization (BIO) is pleased to submit the following comments on the Department of Health and Human Services’ (HHS) Centers for Medicare & Medicaid Services (CMS) proposed rule on the Medicaid, Children’s Health Insurance Programs (CHIP) and Exchanges Eligibility and Essential Health Benefits (EHB) provisions of the Patient Protection and Affordable Care Act (PPACA).
CED: BIO's Comments in response to the Centers for Medicare and Medicaid Services’ (CMS) Draft Guidance for the Public, Industry, and CMS Staff Coverage with Evidence Development in the context of coverage decision
January 28 2013
340B: BIO’s Comments to HRSA Regarding the Burden to Conduct 340B Audits
December 21 2012
EHB: BIO’s Comments on the Essential Health Benefits Proposed Rule
December 21 2012
More Letters, Testimony & Comments →

Press Releases

BIO Applauds House Committee Vote to Repeal IPAB
March 6 2012
BIO applauded the House Energy and Commerce Committee’s passage of the Medicare Decisions Accountability Act, H.R. 452, which would repeal the Independent Payment Advisory Board (IPAB) established in the health care reform law.
BIO Announces Policy Panel Keynote Session for 2011 BIO International Convention
April 19 2011
Democratic and Republican party leaders and strategists will share their differing perspectives in a keynote panel, titled "The Future of Healthcare Reform," during a Keynote Luncheon at the 2011 BIO International Convention.
The Future of Healthcare Policy to be Plenary Discussion at 13th Annual BIO CEO & Investor Conference
February 9 2011
BIO announces that former Senator John B. Breaux (D-LA), former Member, Senate Finance Committee, along with former Congressman Jim McCrery III (R-LA), former Ranking Member, House Ways & Means Committee, will be panelists at the 13th Annual BIO CEO & Investor Conference.
Challenges in Reimbursement Hamper Development of Novel Diagnostics
January 6 2011
BIO releases a report by Health Advances on the limitations of the nation’s reimbursement system for novel diagnostics and the impact of these limitations. 
Media Registration for the 2011 BIO International Convention Now Available Online
January 3 2011
The 2011 BIO International Convention will highlight the latest trends and the newest opportunities for executives, investors, scientists, policy leaders, and media from around the world.
More Press Releases →